Brain Metastases
📧 Sign up to get email alerts when something new happens for Brain Metastases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis [NA]
This clinical trial is evaluating advanced magnetic resonance imaging to identify recurrent brain tumors and radiation necrosis, and it is c…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: nTMS in Planning Stereotactic Radiosurgery in Patients With Brain Metastases in the Motor Cortex [NA]
This clinical trial update describes the use of navigated transcranial magnetic stimulation (nTMS) to plan stereotactic radiosurgery for pat…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study [Phase 2]
This document describes a randomized Phase II clinical trial evaluating intracavitary carrier-embedded Cesium-131 brachytherapy for recurren…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Assessment of Eloquent Function in Brain Tumor Patients
This trial update notes that a study evaluating eloquent function in patients with brain tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating natural killer cell therapy (UD TGFβi NK cells) in combination with temozolomide for patients with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Ex Vivo Drug Response Evaluation for Next Generation Care of Brain Metastases [Phase 2]
Phase 2 clinical trial update from University of Zurich evaluating ex vivo drug response to guide next-generation care of brain metastases; …
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours [NA]
This clinical trial update describes a brain metastases research platform aimed at addressing CNS metastases in solid tumors, sponsored by J…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients With Brain Parenchymal and Leptomeningeal Metastases [Phase 2]
A Phase 2 clinical trial is assessing furmonertinib in combination with intrathecal chemotherapy and stereotactic radiotherapy for EGFR-muta…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors [Phase 3]
This Phase 3 trial is evaluating pre-operative or post-operative stereotactic radiosurgery for patients with surgically resected metastatic …
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Neuropsychological Care for Maintaining Quality of Life After Radiation Therapy in Patients With Brain Metastases [Phase 2]
Phase 2 clinical trial evaluating neuropsychological care to preserve quality of life after radiation therapy in patients with brain metasta…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Study Assessing QBS72S For Treating Brain Metastases [Phase 2]
Stanford University is conducting a Phase 2 trial of QBS72S for brain metastases. The study lists brain metastases, breast cancer, lung canc…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases [Phase 1, Phase 2]
A Phase 1/2 clinical trial is testing stereotactic radiosurgery with olaparib followed by durvalumab and physician's choice systemic therapy…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Asciminib in HER2+ Breast Cancer Brain Metastases [Phase 1, Phase 2]
A clinical trial update indicates Asciminib is being studied in HER2-positive metastatic breast cancer with brain metastases in Phase 1/Phas…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases [Phase 2]
Phase 2 clinical trial update on an anti-PD-1 therapy for melanoma with brain metastases; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial evaluating defactinib and avutometinib, with or without encorafenib, in patients with brain metastases f…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors [EARLY_Phase 1]
Early-phase clinical trial studying Gallium-68 PSMA-11 PET imaging for patients with brain tumors, currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: 7T Brain MRI Scan for Micro-brain Metastasis (microBM) Detection for Patients With Small-cell Lung Cancer (SCLC), Who Decline Prophylactic Cranial Irradiation (PCI)
A clinical trial evaluating the use of 7T brain MRI to detect micro-brain metastases in small-cell lung cancer patients who decline prophyla…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: FSRT Combines With Bevacizumab for Multiple Brain Metastases in Lung Adenocarcinoma [Phase 3]
A Phase 3 clinical trial is evaluating the combination of fractionated stereotactic radiotherapy (FSRT) with bevacizumab for patients with m…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis [Phase 2]
Phase 2 study characterizing the use of the radiotracer 18F-fluciclovine PET to evaluate resected brain metastases and brain cancer.
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases [Phase 2]
This clinical trial is evaluating Utidelone injection plus capecitabine in HER2-negative breast cancer patients with brain metastases in Pha…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Testing of the Anti Cancer Drugs CB-839 HCl (Telaglenastat) and MLN0128 (Sapanisertib) in Advanced Stage Non-small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial update testing Telaglenastat and Sapanisertib in advanced non-small cell lung cancer with brain and leptomeningeal me…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases [Phase 2]
Phase 2b imaging study of RAD101 for suspected recurrent brain metastases is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer [Phase 4]
Phase 4 clinical trial updating on the use of the PET tracer [18F]-FES to image estrogen receptor–positive breast cancer with brain metastas…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: A Randomized Phase II Study Evaluating Upfront SRT to All Brain Metastases Followed by Ivonescimab Plus Chemotherapy Versus Upfront Ivonescimab Plus Chemotherapy in Patients With Asymptomatic Active Brain Metastases From NSCLC [Phase 2]
A randomized Phase II trial evaluates upfront stereotactic radiotherapy to all brain metastases followed by Ivonescimab plus chemotherapy ve…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
This study aims to collect circulating biomarkers from adults with primary brain tumors and brain metastases to build a biomarker repository…